Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway

Cardiovascular damage induced by anticancer therapy has become the main health problem after tumor elimination. Venetoclax (VTX) is a promising novel agent that has been proven to have a high efficacy in multiple hematological diseases, especially acute myeloid leukemia (AML) and chronic lymphocytic...

Descripción completa

Detalles Bibliográficos
Autores principales: AlAsmari, Abdullah F., Alghamdi, Adel, Ali, Nemat, Almeaikl, Muath A., Hakami, Hassan M., Alyousef, Meshal K., AlSwayyed, Mohammed, Alharbi, Metab, Alqahtani, Faleh, Alasmari, Fawaz, Alsaleh, Nasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181135/
https://www.ncbi.nlm.nih.gov/pubmed/35682939
http://dx.doi.org/10.3390/ijms23116260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181135/
https://www.ncbi.nlm.nih.gov/pubmed/35682939
http://dx.doi.org/10.3390/ijms23116260

Ejemplares similares